- Mosaic emerges from stealth with $47M Seed for robotic endovascular navigation
Mosaic emerges from stealth with $47M Seed for robotic endovascular navigation

- Francis Medical gets J&J backing as it seeks a prostate cancer indication
Francis Medical gets J&J backing as it seeks a prostate cancer indication

- Luminoah raises $25M Series B for its FDA-cleared enteral feeding system
Luminoah raises $25M Series B for its FDA-cleared enteral feeding system

- Zimmer Biomet to pay up to $140M for Iovera nerve therapy tech from Pacira BioSciences
Pacira BioSciences has agreed to sell its Iovera nerve therapy device to orthopedic giant Zimmer Biomet in a transaction valued at up to $140 million. Under the terms of the agreement, Zimmer Biomet will provide an upfront payment of $70 million, with the remaining $70 million structured as potentia

- Novocure earns CE mark for Optune Pax pancreatic cancer treatment device
Novocure has successfully secured CE mark approval in Europe for its Optune Pax device, a wearable system designed to treat adults with locally advanced pancreatic cancer. The portable device works by delivering noninvasive, alternating electrical fields- known as Tumor Treating Fields (TTFields) -

- Bioness wins FDA clearance for portable neurostimulator for stroke recovery
Bioness Medical has received FDA 510(k) clearance for its PoNS (Portable Neuromodulation Stimulator) system to treat dynamic gait deficit caused by chronic stroke symptoms. This regulatory milestone significantly expands the commercial indications for the device, building upon its previous authoriza

- United Therapeutics gets FDA green light for lung perfusion device
United Therapeutics announced that the US Food and Drug Administration (FDA) has granted Premarket Approval (PMA) for its LungFX perfusion device. The system, which received regulatory clearance through United Therapeutics’ wholly owned subsidiary, Lung Bioengineering Inc., is explicitly designed fo

- NeuroBell secures €5m in new funding for US launch
Cork-based medical technology company NeuroBell has successfully secured $5.5 million (€4.8 million) in a new investment round to accelerate the United States launch of its LUNA neonatal brain monitor. The funding round was led by Elkstone and saw participation from major existing investors alongsid

- Wearable neurotech company NeuroLife launches with $2.9M to restore movement after stroke
NeuroLife, the market-facing brand of ActivateNeuro, Inc., has launched out of a strategic partnership between Battelle and The NeuroTech Institute to develop non-invasive neurotechnology for stroke and spinal cord injury rehabilitation. The company’s core product is a wearable sleeve that reads ele

- Nanoflex Robotics Awarded €12.5 Million from the EIC Accelerator
Nanoflex Robotics AG has secured €12.5 million in blended financing from the prestigious European Innovation Council Accelerator, consisting of a €2.5 million grant and a €10 million equity investment. The company was one of only 38 businesses selected across Europe from a pool of approximately 1,00

- Lumitron closes USD $50 million investment for HyperVIEW platform
Hancock Prospecting has invested USD $50 million in Lumitron, with the option to increase its funding to USD $100 million this year. This capital injection is dedicated to the commercial scale-up of Lumitron’s HyperVIEW platform, an advanced medical imaging and radiotherapy technology originally dev

- Coherence Neuro begins first clinical study for BCI
Coherence Neuro has initiated its first clinical study of the investigational Cipher brain-computer interface (BCI), marking its transition into human testing. The study, led by Dr. Andrew Morokoff at Royal Melbourne Hospital, evaluates the system during brain tumor resection surgery. Cipher uses a












